Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Najat Khan currently holds 2,290,383 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Najat Khan has been a net seller of RXRX stock. They have purchased $0 and sold $750.6K worth of shares.
Najat Khan's most recent insider trade was on Feb 17, 2026, when they sold 14,280 shares at $3.49 per share.
Najat Khan serves as Executive at RECURSION PHARMACEUTICALS, INC. (RXRX). They have executed 8 insider transactions totaling $750.6K over their tenure at the company.
Najat Khan holds the position of Executive at RECURSION PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Najat Khan has shown a selling trading pattern, with $0 in total purchases and $750.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Najat Khan was on Dec 22, 2025, when they sold $548.6K worth of RXRX shares. This transaction involved 124,403 shares at $4.41 per share.
Najat Khan currently owns 2,290,383 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Najat Khan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Najat Khan has 8 Form 4 filings on record as an insider at RECURSION PHARMACEUTICALS, INC..
Set alerts for Najat Khan and 40,000+ other insiders.